Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study. Garassino MC, He Y, Ahn MJ, Orlov SV, et al. Lung Cancer 2025;202:108417.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Garassino MC, He Y, Ahn MJ, Orlov SV, et al. Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study. Lung Cancer 2025;202:108417.
PMID: 40056874